Transcriptome screening identifies TIPARP as an antiviral host factor against the Getah virus

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Alphaviruses, including the re-emerging Getah virus (GETV), pose a significant public health threat.
• Limited approved antiviral drugs and vaccines exist for alphavirus infections.
• Host antiviral factors represent a promising avenue for therapeutic development.

Purpose of the Study:

• To identify novel host factors that inhibit Getah virus (GETV) replication.
• To investigate the molecular mechanisms underlying host-pathogen interactions in alphavirus infection.

Main Methods:

• Utilized GETV as a model alphavirus for screening host factors.
• Investigated the role of tetrachlorodibenzo-p-dioxin-inducible poly(ADP ribose) polymerase in GETV replication.
• Analyzed the ubiquitination and degradation of viral glycoprotein E2.
• Identified the involvement of the E3 ubiquitin ligase membrane-associated RING-CH8 (MARCH8).

Main Results:

• Tetrachlorodibenzo-p-dioxin-inducible poly(ADP ribose) polymerase was identified as an inhibitor of GETV replication.
• This inhibition occurs through the induction of glycoprotein E2 ubiquitination.
• MARCH8 was recruited to facilitate the degradation of glycoprotein E2.
• The study highlights the importance of viral structural proteins in host factor interactions.

Conclusions:

• The interaction between tetrachlorodibenzo-p-dioxin-inducible poly(ADP ribose) polymerase and GETV glycoprotein E2 provides a new target for antiviral strategies.
• Focusing on host-viral structural protein interactions can uncover novel antiviral host factors.
• This research offers valuable insights for developing new therapies against alphaviruses.